U.S. Markets open in 6 hrs 14 mins

Arch Therapeutics, Inc. (ARTH)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0850-0.0050 (-5.56%)
At close: 3:58PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) -0.28
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.2270
52 Week Low 30.0706
50-Day Moving Average 30.0950
200-Day Moving Average 30.1336

Share Statistics

Avg Vol (3 month) 3375.15k
Avg Vol (10 day) 3157.9k
Shares Outstanding 5236.72M
Implied Shares Outstanding 6N/A
Float 199.34M
% Held by Insiders 113.51%
% Held by Institutions 10.03%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 211:1
Last Split Date 3May 27, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 29, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-55,628.40%

Management Effectiveness

Return on Assets (ttm)-71.34%
Return on Equity (ttm)-691.90%

Income Statement

Revenue (ttm)10k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -5.56M
Net Income Avi to Common (ttm)-5.25M
Diluted EPS (ttm)-0.0270
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.56M
Total Cash Per Share (mrq)0.02
Total Debt (mrq)1.8M
Total Debt/Equity (mrq)87.55
Current Ratio (mrq)3.70
Book Value Per Share (mrq)0.01

Cash Flow Statement

Operating Cash Flow (ttm)-5.15M
Levered Free Cash Flow (ttm)-2.14M